Managing hypertension in patients with chronic kidney diseaseZuber, Kim PA-C, DFAAPA; Gilmartin, Cheryl PharmD; Davis, Jane DNPJournal of the American Academy of PAs: September 2014 - Volume 27 - Issue 9 - p 37–46 doi: 10.1097/01.JAA.0000453239.92473.41 Review Article Buy Abstract Author InformationAuthors Article MetricsMetrics ABSTRACT Chronic kidney disease (CKD) and hypertension are intrinsically linked. Although 59% of the US population will be diagnosed with CKD during their lifetimes, mortality is usually due to a cardiovascular event. Sodium restriction and a combination of a renin-angiotensin-aldosterone medication and a calcium channel blocker are the most effective methods of managing hypertension in patients with CKD. Kim Zuber practices at Metropolitan Nephrology in Alexandria, Va., and is CME chair of the National Kidney Foundation. Cheryl Gilmartin is a clinical assistant professor in the departments of pharmacy practice and nephrology at the University of Illinois Hospital and Health Sciences System in Chicago, Ill. Jane S. Davis is a nurse practitioner at the University of Alabama at Birmingham and a member of the National Kidney Foundation board. The authors have disclosed no potential conflicts of interest, financial or otherwise. Acknowledgment: The authors would like to thank Van Nguyen and Lauren Rothrock, PharmD students at the University of Illinois Hospital and Health Sciences System, for their assistance with this manuscript. © 2014 American Academy of Physician Assistants.